This paper is in the following e-collection/theme issue:

Cancer Epidemiology, Cancer Surveillance and Infodemiology (67) Medicine 2.0: Social Media, Open, Participatory, Collaborative Medicine (1553) Infoveillance, Infodemiology, Digital Disease Surveillance, Infodemic Management (1010) Infodemiology and Infoveillance (1270)

Published on in Vol 8, No 2 (2022): Apr-Jun

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/34073, first published .
The Experiences of Patients With Adjuvant and Metastatic Melanoma Using Disease-Specific Social Media Communities in the Advent of Novel Therapies (Excite Project): Social Media Listening Study

The Experiences of Patients With Adjuvant and Metastatic Melanoma Using Disease-Specific Social Media Communities in the Advent of Novel Therapies (Excite Project): Social Media Listening Study

The Experiences of Patients With Adjuvant and Metastatic Melanoma Using Disease-Specific Social Media Communities in the Advent of Novel Therapies (Excite Project): Social Media Listening Study

Authors of this article:

Guy Faust1 Author Orcid Image ;   Alison Booth2 Author Orcid Image ;   Evie Merinopoulou2 Author Orcid Image ;   Sonia Halhol2 Author Orcid Image ;   Heena Tosar3 Author Orcid Image ;   Amir Nawaz3 Author Orcid Image ;   Magdalena Szlachetka3 Author Orcid Image ;   Gavin Chiu3 Author Orcid Image
Article Authors Cited by (3) Tweetations (4) Metrics

Journals

  1. Haff P, Jacobson A, Taylor M, Schandua H, Farris D, Doan H, Nelson K. The New Media Landscape and Its Effects on Skin Cancer Diagnostics, Prognostics, and Prevention: Scoping Review. JMIR Dermatology 2024;7:e53373 View
  2. Corps K, Terry O, Lopez-Olivo M. Patient Voices in Rheumatic Immune-related Adverse Events. Rheumatic Disease Clinics of North America 2024;50(2):241 View
  3. Cimiano P, Collins B, De Vuono M, Escudier T, Gottowik J, Hartung M, Leddin M, Neupane B, Rodriguez-Esteban R, Schmidt A, Starke-Knäusel C, Voorhaar M, Wieckowski K. Patient listening on social media for patient-focused drug development: a synthesis of considerations from patients, industry and regulators. Frontiers in Medicine 2024;11 View